Search research articles
Contact Us
Filters
Showing results (1-10 of 96) with videos related to
Page
of 10
Sort By:
Current Opinion in Lipidology
|
March 19, 2011
Catching up with important players in atherosclerosis: type I interferons and neutrophils
Heidi Noels, Christian Weber
Frontiers in Immunology
|
March 1, 2016
Editorial: The CXCR4 Ligand/Receptor Family and the DPP4 Protease in High-Risk Cardiovascular Patients
Heidi Noels, Jürgen Bernhagen
Cardiovascular Drugs and Therapy
|
December 25, 2009
Fractalkine as an important target of aspirin in the prevention of atherogenesis : Editorial to: "Aspirin inhibits fractalkine expression in atherosclerotic plaques and reduces atherosclerosis in ApoE gene knockout mice" by H. Liu et al
Heidi Noels, Christian Weber
Toxins
|
June 18, 2020
Editorial on the Special Issue "Comorbidities in Chronic Kidney Disease"
Heidi Noels, Joachim Jankowski
Nature Medicine
|
November 9, 2011
Atherosclerosis: current pathogenesis and therapeutic options
Christian Weber, Heidi Noels
Advanced Drug Delivery Reviews
|
December 14, 2020
Lipids in disease pathology, diagnosis & therapy
Twan Lammers, Heidi Noels
Circulation Research
|
April 13, 2023
Increased Risk of Cardiovascular Complications in Chronic Kidney Disease: Introduction to a Compendium
Heidi Noels, Joachim Jankowski
Hamostaseologie
|
January 15, 2015
Potential cell-specific functions of CXCR4 in atherosclerosis
Christian Weber, Yvonne Döring, Heidi Noels
Trends in Cardiovascular Medicine
|
August 15, 2009
Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis
Heidi Noels, Jürgen Bernhagen, Christian Weber
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 20, 2012
The use of high-throughput technologies to investigate vascular inflammation and atherosclerosis
Yvonne Döring, Heidi Noels, Christian Weber
Page
of 10
Search research articles
Search
Showing results (1-10 of 96) with videos related to
Sort By:
Page
of 10
Current Opinion in Lipidology
|
March 19, 2011
Catching up with important players in atherosclerosis: type I interferons and neutrophils
Heidi Noels, Christian Weber
Frontiers in Immunology
|
March 1, 2016
Editorial: The CXCR4 Ligand/Receptor Family and the DPP4 Protease in High-Risk Cardiovascular Patients
Heidi Noels, Jürgen Bernhagen
Cardiovascular Drugs and Therapy
|
December 25, 2009
Fractalkine as an important target of aspirin in the prevention of atherogenesis : Editorial to: "Aspirin inhibits fractalkine expression in atherosclerotic plaques and reduces atherosclerosis in ApoE gene knockout mice" by H. Liu et al
Heidi Noels, Christian Weber
Toxins
|
June 18, 2020
Editorial on the Special Issue "Comorbidities in Chronic Kidney Disease"
Heidi Noels, Joachim Jankowski
Nature Medicine
|
November 9, 2011
Atherosclerosis: current pathogenesis and therapeutic options
Christian Weber, Heidi Noels
Advanced Drug Delivery Reviews
|
December 14, 2020
Lipids in disease pathology, diagnosis & therapy
Twan Lammers, Heidi Noels
Circulation Research
|
April 13, 2023
Increased Risk of Cardiovascular Complications in Chronic Kidney Disease: Introduction to a Compendium
Heidi Noels, Joachim Jankowski
Hamostaseologie
|
January 15, 2015
Potential cell-specific functions of CXCR4 in atherosclerosis
Christian Weber, Yvonne Döring, Heidi Noels
Trends in Cardiovascular Medicine
|
August 15, 2009
Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis
Heidi Noels, Jürgen Bernhagen, Christian Weber
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 20, 2012
The use of high-throughput technologies to investigate vascular inflammation and atherosclerosis
Yvonne Döring, Heidi Noels, Christian Weber
Page
of 10